The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBA
What they do
Biorelate uses natural language processing and machine learning to extract structured causal relationships from unstructured scientific literature. Pharmaceutical and biotech researchers license their Galactic platform to uncover hidden biomedical insights, identify novel targets, and inform pipeline strategy.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Biomedical data curation
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- Manchester, UK
- Region
- Europe
- Founded
- 2014
- Total funding
- $11M raised
Notable investors: YFM Equity Partners, Maven Capital Partners, Triple Point Ventures.
Also in Pharma & Drug Discovery
Related on The Signal
Dr. Dereck Mush, MD, MBA
What Pharma Is Buying From AI Drug Discovery: Inside AstraZeneca’s insitro Deal
Dr. Dereck Mush, MD, MBA
Is AI Drug Discovery Actually Working? What the 2026 Clinical Trial Data Shows
Dr. Dereck Mush, MD, MBA
Closing the Assay Loop: Inside Anthropic's $400M Wet Lab Pivot
Dr. Dereck Mush, MD, MBA